In a report released today, Michael Albanese from EF Hutton reiterated a Buy rating on Upexi (UPXI – Research Report), with a price target of $7.00. The company’s shares closed yesterday at $3.95.
Albanese covers the Technology sector, focusing on stocks such as Golden Matrix Group, FiscalNote Holdings, and Glimpse Group. According to TipRanks, Albanese has an average return of -0.2% and a 50.00% success rate on recommended stocks.
Currently, the analyst consensus on Upexi is a Moderate Buy with an average price target of $7.00.
See the top stocks recommended by analysts >>
Based on Upexi’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $11.56 million and a GAAP net loss of $2.6 million. In comparison, last year the company earned a revenue of $3.87 million and had a net profit of $511.71 thousand
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Grove Inc is engaged in the business of developing, producing, marketing and selling raw materials, white label products and end consumer products containing the industrial hemp plant extract, cannabidiol. The company sells to numerous consumer markets including the botanical, beauty care, pet care and functional food sectors.
Read More on UPXI:
